Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study

K. Reich, A. Pinter, J. P. Lacour, C. Ferrandiz, G. Micali, L. E. French, M. Lomaga, Y. Dutronc, C. Henneges, S. Wilhelm, S. Hartz, C. Paul

Producció científica: Contribució a revistaArticleRecercaAvaluat per experts

170 Cites (Scopus)

Fingerprint

Navegar pels temes de recerca de 'Comparison of ixekizumab with ustekinumab in moderate-to-severe psoriasis: 24-week results from IXORA-S, a phase III study'. Junts formen un fingerprint únic.

Keyphrases

Medicine and Dentistry